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SUMMARY
Astrocytes constantly adapt their ramified
morphology in order to support brain cell assem-
blies. Such plasticity is partly mediated by ion and
water fluxes, which rely on the water channel aqua-
porin-4 (AQP4). The mechanism by which this chan-
nel locally contributes to process dynamics has
remained elusive. Using a combination of single-
molecule and calcium imaging approaches, we
here investigated in hippocampal astrocytes the dy-
namic distribution of the AQP4 isoformsM1 andM23.
Surface AQP4-M1 formed small aggregates that
contrast with the large AQP4-M23 clusters that are
enriched near glutamatergic synapses. Strikingly,
stabilizing surface AQP4-M23 tuned the motility
of astrocyte processes and favors glutamate syn-
apse activity. Furthermore, human autoantibodies
directed against AQP4 from neuromyelitis optica
(NMO) patients impaired AQP4-M23 dynamic distri-
bution and, consequently, astrocyte process and
synaptic activity. Collectively, it emerges that the
membrane dynamics of AQP4 isoform regulate brain
cell assemblies in health and autoimmune brain dis-
ease targeting AQP4.
INTRODUCTION
Astrocytes are essential cells of the CNS, ensuring keymetabolic
and signaling functions in brain cell assemblies. They have high
morphological complexity with extended and ramified pro-
cesses that are intimately associated with synapses both at
the structural level through the coverage of spines and presyn-
aptic terminals and at the functional level through the release
of gliotransmitters (Halassa and Haydon, 2010; Panatier et al.,
2006; Theodosis et al., 2008; Volterra and Meldolesi, 2005) and
the uptake of neurotransmitters. Astrocytes can, in addition,
sense neuronal activity and rapidly restructure their processes
near synaptic elements (Bernardinelli et al., 2014; Oliet et al.,
2001; Perez-Alvarez et al., 2014). The movement of water
through the plasmamembrane constitutes one of themain hypo-
thetical pathways by which astrocytes tune their volume and
regulate the motility of their processes (Reichenbach et al.,
2010). Indeed, astrocytes rapidly swell or shrink in response to
a shift of osmolytes and water between the extracellular and
intracellular compartments (Mongin and Kimelberg, 2005). In as-
trocytes, watermovement ismediatedmostly by thewater chan-
nels aquaporin-4 (AQP4) (Kimelberg, 2004; Manley et al., 2000),
which are located predominantly onto perivascular endfeet
(Nagelhus and Ottersen, 2013) and, to a lesser extent, onto pro-
cesses facing excitatory synapses (Amiry-Moghaddam and Ot-
tersen, 2003). AQP4 exists in two main isoforms, M1 and M23,
which exhibit similar water transport capacities but different ag-
gregation properties and cellular distribution onto astrocytes
(Crane et al., 2010; Smith et al., 2014). At the structural level,
the two isoforms have similar extracellular domains but different
intracellular ones (Crane et al., 2010; Smith et al., 2014). In addi-
tion, these two isoforms have different surface-trafficking char-
acteristics in pure cultured astrocytes (Crane et al., 2008,
2010). Thus, the possibility that AQP4 isoforms differentially con-
trol astrocytic process motility, through distinct membrane orga-
nization, has emerged and gained support.
Using a combination of super-resolution, single-molecule, and
calcium imaging approaches, we here demonstrated that the
surface trafficking of AQP4 isoforms differentially modulates as-
trocytic process motility and excitatory neurotransmission. By
imaging astrocytic motility and neuronal Ca2+ transient while
artificially immobilizing AQP4 onto astrocytes, we demon-
strated that among the two isoforms, the surface trafficking of
AQP4-M23 mainly regulates astrocyte process motility and glu-
tamatergic-dependent synaptic transmission. As autoantibodies
directed against AQP4 are found in patients with the demyelin-
ating autoimmune disease neuromyelitis optica (NMO-Ig) (Len-
non et al., 2005) and strongly damage astrocyte functions
through various immune mechanisms (Ratelade and Verkman,
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2012), we investigated whether NMO-IgG perturbs AQP4 sur-
face dynamics and distribution. Strikingly, AQP4 surface traf-
ficking was strongly altered in the presence of NMO-IgG. The
autoantibodies destabilized AQP4-M23 isoform, decreased
astrocyte motility, and ultimately reduced NMDA receptor
(NMDAR)-mediated synaptic activity. Altogether, we unveil a
physiopathological interplay between astrocytic process motility
and AQP4-M23 dynamics, shedding light on the regulatory mo-
lecular mechanisms underpinning the tripartite synapse.
RESULTS
Trafficking and Nanoscale Distribution of Surface AQP4
Isoforms in Hippocampal Cell Networks
The membrane trafficking of AQP4-M1 and AQP4-M23 was first
measured in cultured hippocampal cells, composed of neurons,
astrocytes, and microglia (Figure 1A), by imaging a single nano-
particle (quantum dot [QD]) coupled to one tagged AQP4 isoform
(Figure 1B). Because the two isoforms (M1 and M23) have iden-
tical extracellular domains and thus cannot be distinguished with
extracellular antibodies, a myc epitope was genetically inserted
into the second extracellular loop of AQP4-M1 and AQP4-M23,
allowing specific live immunostaining and single-nanoparticle
tracking (Figure 1B). Of note, the expression of AQP4myc in astro-
cytes did not result in significant overexpression of the trans-
porter (Figures S1A). The presence of the extracellular myc tag
did not alter AQP4 water transport, measured by a gold-stan-
dard osmotic swelling assay (Madeira et al., 2016), in AQP4myc
transfected oocytes (Figure S1B). The use of tagged AQP4 and
nanometer-size QD particles allowed us to track AQP4 com-
plexes located at the surface of identified astrocytes. During
our 30 min imaging experiments, the vast majority of tagged
AQP4 was at the surface of astrocytes, as only few AQP4-QDs
were detected inside astrocyte after acid wash treatment (Fig-
ure S1C) (Tardin et al., 2003). First, we compared the surface dy-
namics of AQP4-M1 and AQP4-M23 in the somatic and process
compartments of highly polarized astrocytes (Figure 1C). AQP4-
M1 diffusionwas higher in processes comparedwith the somatic
compartment (Figure 1D), whereas AQP4-M23 diffusion was
lower in processes (Figure 1D). This indicates that themembrane
trafficking of AQP4-M1 and AQP4-M23 is different onto astro-
cytes embedded into spontaneously active neuronal networks.
Figure 1. Surface Lateral of AQP4 Cluster in
Hippocampal Mixed Culture and Slices
(A) Immunofluorescence showing mixed hippo-
campal cultures with astrocytes (red), neurons
(blue), and microglia (arrowhead, magenta). Scale
bar, 40 mm.
(B) Scheme of myc-tagged AQP4 (AQP4myc) tar-
geted by an anti-myc antibody (coupled to quan-
tum dot [QD]). Bottom: immunostaining of MAP2
(neuronal dendrites), GFAP (glial cells), and Myc
(transfected AQP4). Scale bar, 40 mm.
(C) Examples of astrocytes transfected with GFP
and either AQP4-M1myc or AQP4-M23myc. Insets,
DIC images of the corresponding mixed hippo-
campal cells. Scale bars (both images), 5 mm.
(D) Representative of AQP4-M1myc and AQP4-
M23myc trajectories (!25 s duration) onto astro-
cyte processes. Right: instantaneous diffusion
coefficients of AQP4-M1myc (blue) and AQP4-
M23myc (orange) onto astrocyte soma (nAQP4-M1 =
1,541, nAQP4-M23 = 2,200 trajectories) and
processes (nAQP4-M1 = 1,405, nAQP4-M23 = 2,600
trajectories). Scale bar, 0.5 mm.
(E) Schematic representation of hippocampal or-
ganotypic slice in which astrocytes have been
electroporated with GFP and one AQP4myc sub-
type. Right: scheme of myc-tagged AQP4
(AQP4myc) targeted by an anti-myc antibody
(coupled to quantum dot [QD]).
(F) Examples of astrocytes transfected with GFP
and either AQP4-M1myc or AQP4-M23myc. Insets:
enlarged astrocyte processes. Scale bars (both
images), 5 mm.
(G) Three examples of AQP4-M1myc (blue)
and AQP4-M23myc (orange) trajectories. Right:
instantaneous diffusion coefficient of AQP4-M1myc
(M1) and AQP4-M23myc (M23) (nAQP4-M1 = 392,
nAQP4-M23 = 340 trajectories). Scale bar, 0.5 mm.
In (D) and (G), data are presented as median ±
25%–75% interquartile range (IQR) (mm2 s"1)
(*p = 0.02 and ***p < 0.0001, Mann-Whitney test).
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As astrocytes from primary cultures and brain slices differ in
their morphology, which may influence trafficking of membrane
proteins, we performed single-QD tracking of AQP4 isoforms
on astrocytes within hippocampal organotypic slices, as previ-
ously pioneered on astrocytes with another transporter (Al
Awabdh et al., 2016) and in neurons (Varela et al., 2016a,
2016b). The AQP4myc isoforms and GFP were electroporated
in astrocytes from hippocampal slices, and single-QD detection
and tracking in organotypic slices was performed (Figures 1E
and 1F), as recently described (Varela et al., 2016a, 2016b).
Both AQP4-M1 and AQP4-M23 diffuse in the plasma membrane
of astrocytes in hippocampal slices, while exhibiting different dy-
namics distribution (Figure 1G). Thus, besides providing evi-
dence of single-molecule dynamics of AQP4 in hippocampal
brain slice, our data collectively indicate that exogenously ex-
pressed AQP4-M1 and AQP4-M23 isoforms have differential dy-
namics at the surface of hippocampal astrocytes.
We then investigated the surface organization of AQP4 isoforms
from ex vivo and in vitro astrocytes. In slices, we took advantages
of the human anti-AQP4 immunoglobulins from NMO patients,
which recognize extracellular domains of AQP4 (irrespective of
isoforms), as a mean to immunostain all membrane AQP4 what-
ever the isoform. This staining was then compared with that of
each isoform from cultured astrocytes (Figures 2A and 2B). The
Figure 2. AQP4 Cluster Organization and Nanoscale Distribution in Hippocampal Organotypic Slices and Mixed Cultures
(A) Schematic representation of cultured astrocyte expressing myc-tagged AQP4 (AQP4myc) targeted by an anti-myc antibody (coupled to organic fluorophores)
and astrocyte from hippocampal slice expressing endogenous AQP4 (stained with NMO antibodies). Right: immunostaining of surface AQP4 clusters in mixed
culture (top) and slice (bottom). Scale bar, 200 nm.
(B) Comparison of AQP4 cluster area between conditions. Right: distributions of AQP4 cluster areas between hippocampal cultures (brown) and slices (gray)
(n = 20 regions for each condition).
(C and D) Wide-field (left) and dSTORM (right) images of astrocytes transfected with AQP4-M1myc (C) or AQP4-M23myc (D). Dotted lines represent the border of
astrocytes on the basis of GFP epifluorescence images. Scale bars, 10 mm.
(E) dSTORMmagnified images of surface AQP4myc subtype clusters onto astrocytic processes (top) and individual clusters (bottom). Scale bars, 2.5 mm (top) and
100 nm (bottom).
(F) Comparison of AQP4-M1myc (blue) and AQP4-M23myc (orange) cluster area from dSTORM images (median ± IQR). Right: normalized number of AQP4myc
clusters (n = 24 regions).
In (B), data are presented as mean 3 105 ± SEM (p = 0.12, one-way ANOVA). In (F), data are presented as median 3 104 ± IQR and median 3 10"2 ± IQR (nm2)
(***p < 0.0001, Mann-Whitney test).
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average cluster area of surface AQP4 from hippocampal slices
was similar to that of AQP4-M1 and AQP4-M23 together (Figures
2A and 2B), indicating that the surface organization of AQP4 does
not significantlydifferbetweenastrocytes fromdissociatedculture
and brain slice. Yet it has been previously shown that AQP4-M1
and AQP4-M23 are differentially organized (Furman et al., 2003;
Smith and Verkman, 2015; Smith et al., 2014). In order to map
morespecifically surfaceAQP4-M1andAQP4-M23onastrocytes,
we used both classical confocal microscopy and the single-mole-
cule localizationmicroscopy technique of direct stochastic optical
reconstruction microscopy (dSTORM) (Heilemann et al., 2008) to
provide the nanoscale architecture of these two membrane pro-
teins. First, diffraction-limited confocal imaging showed that
AQP4-M1 forms surface clusters that are smaller than AQP4-
M23 ones (Figures 2A and 2B) and revealed distinct distributions
between AQP4-M1 and AQP4-M23 (Figures 2C and 2D). Note-
worthy, we immunostained fixed astrocytes with anti-myc anti-
body to confirm that the 30 min incubation in live astrocytes did
not induce clustering of surface AQP4 (Figure S1D). dSTORM
imaging confirmed that at the nanoscale level, the organization
of surface AQP4 subtypes is different, with a diffuse and uniform
distribution of AQP4-M1 and a non-uniform distribution of AQP4-
M23with large clusterspreferentially located at the edgesof astro-
cyte processes (Figures 2C–2F). Consistently, AQP4-M1 clusters
are more frequent, and smaller, than AQP4-M23 (Figure 2F).
Thus, these data indicate that although both isoforms dynamically
explore the astrocyte surface, their trafficking properties differ
according to the astrocytic domains, fueling a model in which
AQP4-M1 fast dynamics in processes are associated with an
Figure 3. Correlation between Astrocyte
Process Motility and AQP4 Isoform Content
(A and B) Time-lapse images of GFP-positive
astrocyte processes in which surface AQP4-M1myc
(A) or AQP4-M23myc (B) was labeled. White ar-
rowheads highlight extension, and white circles
highlight retraction. Dotted lines represent astro-
cyte borders. Scale bars, 2 mm.
(C and D) Correlation between the number of
clusters versus process motility (P.M.) (n = 40 as-
trocytes). Regression fit ± SD is displayed. p = 0.25
(AQP4-M1; C) and **p = 0.003 (AQP4-M23; D)
(Spearman correlation test). Analysis of astrocytic
process motility can be found in Figure S2.
evendistributionof small clusters,whereas
AQP4-M23 slower dynamics would favor
the formation of large clusters.
AQP4 Surface Trafficking
Contributes to Astrocytic Process
Motility in an Isoform-Dependent
Manner
Whether the differential nanoscale organi-
zation and dynamics of AQP4-M1 and
AQP4-M23 onto processes affect their
functions, such as their motility, thus
emerges as an intriguing possibility. First,
we performed a time-lapse imaging for
more than 30 min of astrocytic processes co-expressing GFP
and either AQP4-M1 or AQP4-M23 and quantified the process
motility (Figure S2). There was no correlation between the num-
ber of AQP4-M1 clusters onto the astrocyte processes and their
motility (Figures 3A and 3C; r2 = 0.18, p = 0.25). In contrast, pro-
cesses with a larger number of AQP4-M23 displayed a higher
motility, resulting in a significant positive correlation (Figures
3B and 3D; r2 = 0.5, p = 0.003). The large AQP4-M23 clusters,
but not AQP4-M1 ones, could thus have an instrumental role in
the astrocytic process motility.
To experimentally address this possibility, we manipulated
AQP4 dynamics by using a cross-linking (x-link) strategy (Dupuis
et al., 2014; Groc et al., 2008; Heine et al., 2008; Murphy-Royal
et al., 2015). Schematically, AQP4 isoforms were immobilized
at the cell surface with a high concentration (200 mg/mL) of pri-
mary antibody directed against myc tag (Figure 4A). At first, we
controlled that the x-link assay alters the surface trafficking of
the targeted AQP4 subtypes without affecting their water trans-
port function. Xenopus oocytes immersed into distilled water
(hypotonic stress) quickly swelled and lysed when expressing
AQP4, a process prevented by the presence of AQP4 inhibitors
(Igarashi et al., 2011; Migliati et al., 2009) (Figures 4B and S3A).
The swelling, which is due to water movement through AQP4,
was not altered by the high concentration of antibodies used
for x-link (Figures 4B and S3A), indicating that AQP4-M23 func-
tion remained intact in this condition. As expected, the surface
trafficking of AQP4-M23 was strongly reduced by the x-link
procedure, increasing the size of existing clusters (Figures 3D
and 4C). What then was the impact of this artificial alteration of
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AQP4-M23 dynamics and distribution on the astrocyte process
motility? Remarkably, AQP4-M23 x-link significantly increased
astrocytic process motility by 50% (Figure 4E), indicating that
AQP4-M23 dynamic organization at the surface of astrocytes af-
fects their process motility. Regarding AQP4-M1, their x-linking
induced the formation of large clusters never observed in basal
conditions (Figure S3). Then we investigated the impact of these
artificially created AQP4-M1 clusters on process motility, with
the reasoning that the creation of large clusters, like those natu-
rally observed with AQP4-M23, may be sufficient to favor pro-
cess motility, irrespective of the AQP4 subtype. However, the
AQP4-M1 x-link decreased astrocyte process motility (Fig-
ure S3E), suggesting that the non-clustered distribution of
AQP4-M1 in steady-state conditions possibly contributes to
the basal motility of processes and that AQP4-M23 dynamic
and clustering has a specific role in regulating astrocyte process
motility.
Neuronal Activity Bi-directionally Regulates AQP4
Surface Trafficking and Astrocytic Process Motility
Given that the neuronal activity regulates astrocytic process
motility (Bernardinelli et al., 2014; Perez-Alvarez et al., 2014),
we explored the possibility that AQP4 dynamics and distribu-
tion, especially those of AQP4-M23, are sensitive to neuronal
network firing and contribute to the neuron-astrocyte cross-
talk. First, AQP4 isoform dynamics were evaluated in the
Figure 4. Immobilization of AQP4-M23 Affects Surface Cluster Size and Astrocytic Motility
(A) Schematic representation of myc-tagged AQP4 (AQP4myc) that were x-linked through anti-myc antibodies.
(B) Survival rate of oocytes expressing either no AQP4 (unrelated plasmid) or AQP4-M23myc over time (left) and after 20min (right) of exposure to x-link antibodies
or the AQP4 inhibitors bumetanide (75 mM) and TGN-020 (500 mM) (n = 60 oocytes injected for each condition).
(C) Representative AQP4-M23 trajectories in control and x-link conditions. Right: normalized instantaneous diffusion coefficient in control and x-link conditions
(control [Ctrl], n = 697; x-link, n = 632 trajectories). Scale bar, 0.5 mm.
(D) Immunostaining (left) and comparison (right) of surface AQP4-M23 cluster size in control and x-link conditions (n = 30 regions for each condition). Scale bar,
200 nm.
(E) Time-lapse imaging of GFP-expressing astrocytes before and after exposure to AQP4-M23 x-link. White arrowheads highlight extension, and white circles
highlight retraction. Right: comparison of process motility (P.M.) calculated for individual process (n = 185 regions from 14 astrocytes; ***p < 0.0001, Mann-
Whitney test). Scale bar, 2 mm.
In (B) and (C), data are represented asmean ± SEM (***p < 0.0001, one-way ANOVA, and ***p < 0.0001, Mann-Whitney test, respectively). Data are represented in
(D) as mean 3 106 ± SEM (***p < 0.0001, Mann-Whitney test).
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non-physiological condition with only astrocytes (neuron free).
Strikingly, surface AQP4-M23 was nearly immobile, whereas
the AQP4-M1 diffusion coefficient was only slightly affected
compared with mixed glio-neuronal network condition (Figures
5A and S4A). These observations in pure cultured astrocytes,
which display a balloon-like shape with virtually no process,
suggest that AQP4-M23 trafficking is highly sensitive to the
presence of neurons, neuronal activity, and/or astrocyte pro-
cesses. Next, mixed hippocampal cultured networks were
exposed to either 1 mM tetrodotoxin (TTX; a voltage-gated so-
dium channel blocker) to prevent action potential and repress
neuronal firing, or to 100 mM glutamate to depolarize neurons
and increase neuronal firing. As previously reported (Rusakov,
2015), we confirmed that astrocytic process motility decreased
in the presence of TTX and, inversely, increased in the pres-
ence of glutamate (Figures 5B and S4B). As expected from
the correlation between AQP4-M23 dynamic distribution and
process motility, TTX and glutamate applications bi-direction-
ally regulated AQP4-M23 surface trafficking. In TTX-silenced
neuronal networks, the downregulation of process motility
was associated with an increase in AQP4-M23 trafficking (Fig-
ure 5C). In the glutamate condition, the upregulation of process
motility was associated with a decrease in AQP4-M23 traf-
ficking (Figure 5C). The dynamics of AQP4-M1 were also sen-
sitive to changes in neuronal activity (Figure S4C) but to a
lesser extent compared with AQP4-M23 (Figure S4C). Collec-
tively, these results indicate that AQP4-M23 trafficking is highly
sensitive to neuronal activity, further supporting an instrumental
role of AQP4-M23 dynamic distribution in the activity-depen-
dent regulation of astrocytic process motility.
AQP4M23 Dynamics Near Glutamate Synapse Regulate
Astrocyte Motility and Synaptic Events
The structural plasticity of astrocytic processes plays an impor-
tant role in the development and physiology of the glutamate
synapse, mostly through changes in the astrocytic coverage of
pre- and postsynaptic compartments (Araque et al., 1999;
Reichenbach et al., 2010; Ventura and Harris, 1999; Volterra
andMeldolesi, 2005). Consistent with the presence of a dynamic
interplay between synapses and astrocytes, we observed that
astrocytic process motility was higher near presynaptic termi-
nals labeled with FM4-64 dye (Figure 6A). As AQP4-M23 surface
clusters are important for astrocytic process motility, we tested
whether AQP4-M23 organization regulates the glutamatergic
basal synaptic transmission. First, immunostaining of surface
AQP4-M1 and AQP4-M23 with the postsynaptic protein Homer
1c revealed that AQP4-M23 clusters were enriched onto astro-
cytic processes near glutamate synapses (Figure 6B). Consis-
tently, membrane AQP4-M23 were trapped near synapses, as
demonstrated by their reduced diffusion coefficient and
increased dwell time in this compartment (Figures 6C and 6E).
In contrast, AQP4-M1 was neither enriched nor retained near
synapses (Figures 6B, 6D, and 6E). Then, to directly test whether
AQP4-M23 organization on astrocyte process regulates the
glutamate synapse transmission, AQP4-M23 was x-linked onto
astrocytes whilemeasuring spontaneousNMDAR-mediated cal-
cium transients (isolated in presence of bicuculline, nifedipine,
and Mg2+ free) into adjacent dendritic protrusions. Schemati-
cally, hippocampal neurons were transfected with the geneti-
cally encoded Ca2+ indicator GCaMP3, and astrocytes were
transfected with AQP4-M23myc (or AQP4-M1myc; see STAR
Methods). Expectedly, the addition of the NMDAR competitive
antagonist APV (50 mM) completely abolished the calcium
events, indicating that these events are mediated by NMDARs.
Strikingly, NMDAR-mediated calcium transients were signifi-
cantly more frequent in protrusions near AQP4-M23 x-link-
induced high astrocytic process motility (Figure 6F), indicating
that alterations of the AQP4-M23 dynamic organization and
subsequent increased process motility are translated to the
neighboring synapses. The NMDAR-mediated calcium tran-
sients were unaltered in protrusions near astrocytic processes
in which AQP4-M1 dynamics were abolished (Figure 6F). Alto-
gether, these data reveal that the dynamics and organization of
AQP4-M23, but not of AQP4-M1, affect basal spontaneous syn-
aptic transmission, most likely through the regulation of astro-
cyte process motility.
Figure 5. Activity-Dependent Regulation of
AQP4 Surface Diffusion and AstrocyticMotility
(A) Trajectories of AQP4-M1myc or AQP4-M23myc
onto neuron-free astrocyte culture. Scale bars, 5 mm
and 0.5 mm (insets). Right: comparison of instanta-
neous diffusion coefficients of AQP4-M1myc or AQP4-
M23myc trajectories (pure astrocyte [astro]; M1astro,
n = 833;M1mixed, n = 4,400;M23astro, n = 737;M23mix,
n = 6,200 trajectories).
(B) Mixed hippocampal cultures were exposed to TTX
(1 mM) or glutamate (100 mM) for 20 min. Normalized
process motility (P.M.) before and after application of
TTX or glutamate (nTTX = 22, nGlu = 24 astrocytes).
(C) Trajectories of AQP4-M23myc onto GFP-ex-
pressing astrocytes from mixed hippocampal cul-
tures exposed to TTX (1 mM) or glutamate (100 mM) for
20 min. Insets: enlarged representative trajectories.
Right: comparison of the normalized instantaneous
diffusion coefficients between conditions (nctrl = 500, nTTX = 501, nGlu = 584 trajectories). Scale bars, 5 mm and 0.5 mm (insets).
Data are presented in (A) as median ± IQR (**p = 0.006 and ***p < 0.0001, one-way ANOVA), in (B) as SD (**p = 0.004 and ***p < 0.0001, Mann-Whitney test), and in
(C) as mean ± SEM (*p = 0.02, 0.015, and ***p < 0.0001, one-way ANOVA).
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Figure 6. AQP4-M23 Aggregates around Synapses and Tunes Locally Astrocytic Motility
(A) Time-lapse images of GFP-expressing astrocyte processes depicting movements near activated synapse (labeled with FM4-64 dye). White arrowheads
highlight extension, and white circles highlight retraction. Process motility (P.M.) of astrocyte processes surrounding (synaptic [syn.]) or away (outside [out.])
synapses (syn., n = 54; out., n = 50). Scale bar, 250 nm.
(B) Confocal microscopy images of surface AQP4-M1myc or AQP4-M23myc and postsynaptic density protein of glutamatergic synapses (Homer 1c). Normalized
number of synaptic AQP4-M1myc or AQP4-M23myc clusters in the vicinity of glutamatergic synapses (n = 20 regions). Scale bar, 1 mm.
(C and D) Representative AQP4-M23myc (C, orange) and AQP4-M1myc (D, blue) trajectories near glutamatergic synapses (Homer 1c). The perisynaptic areas
(dotted line) correspond to 500 nm distance. Right: cumulative distributions inside and outside synaptic areas (AQP4-M23: nsyn. = 178, nout. = 820; AQP4-M1:
nsyn. = 117, nout. = 503 trajectories). Scale bar, 0.5 mm.
(E) Dwell time of AQP4-M1myc (blue) and AQP4-M23myc (orange) trajectories near synapses (nAQP4M1 = 117, nAQP4M23 = 178).
(legend continued on next page)
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NMO Autoantibodies Modify Synaptic Transmission
through Alteration of AQP4 Trafficking
Although the above antibody-induced alterations of AQP4
membrane distribution are artificial, autoantibodies directed
against extracellular epitopes of AQP4 have been characterized
in patients with NMO (Hinson et al., 2008, 2012; Marignier et al.,
2010, 2016; Ratelade and Verkman, 2012; Ratelade et al.,
2011; Rossi et al., 2012). These autoantibodies induce major
dysfunctions of brain cell circuits, associated with severe clin-
ical symptoms. To test whether the molecular mechanism by
which these autoantibodies impair AQP4 function also involves
alteration of water transporter dynamics and distribution on as-
trocytes, we purified NMO-IgG from three NMO patients who
tested strongly positive for AQP4 IgG (Figure 7A). First, we eval-
uate whether NMO autoantibodies act as blockers of AQP4
function. For this, oocytes expressing AQP4-M23myc or
AQP4-M1myc were exposed to serum containing NMO-IgG for
30 min and then immersed in hypotonic solution. NMO-IgG
does not appear to alter water transport, as cell lysis of oocytes
expressing AQP4-M23myc or AQP4-M1myc exposed to NMO-
IgG was comparable with that of oocytes transfected alone
or exposed to control (non-specific) IgG (Figure 7B). We next
tested whether NMO-IgG alters the dynamics and distribution
of AQP4 subtypes. Strikingly, when hippocampal networks
were exposed to NMO-IgG (30 min), AQP4-M23 surface traf-
ficking was increased as a result of disorganization of AQP4-
M23 clusters whose size consistently decreased (Figures 7C
and 7E). On the other hand, AQP4-M1 surface trafficking was
decreased as a result of an aggregation of AQP4-M1 clusters
that consistently increased (Figures 7D and 7E). Exposure of
hippocampal networks to NMO-IgG therefore affected the sur-
face trafficking of both AQP4 subtypes. On the basis of the
above data, one would then predict that astrocytic process
motility and synaptic NMDAR-mediated events will be
decreased in hippocampal networks exposed to NMO-IgG.
Consistently, NMO-IgG incubation decreased astrocyte pro-
cess motility by approximately 50% (Figures 7F and S5A)
whereas exposure to control IgG had no impact (Figure S5B).
As NMO-IgG targets both isoforms, we controlled that
exposing astrocytes expressing either AQP4-M1myc or AQP4-
M23myc to NMO-IgG produced similar outcomes (Figure S5A).
At the synaptic level, the frequency of synaptic NMDAR-medi-
ated Ca2+ transients was significantly reduced in NMO-IgG-
exposed neurons (Figure 7G). Collectively, these data indicate
that acute exposure to NMO-IgG from patients strongly alters
AQP4 surface dynamics, without affecting its function. The
surface re-organization of AQP4 isoforms led to functional
alteration of astrocyte process motility and basal synaptic
transmission. On the basis of the key role of AQP4-M23 dy-
namics on the excitatory synaptic transmission, the NMO-IgG
would thus likely affect the astrocyte-neuron interplay through
their action on AQP4-M23 membrane distribution.
DISCUSSION
Using a combination of super-resolution, single-molecule, and
calcium imaging approaches, we here demonstrate that the sur-
face dynamics and nanoscale organization of AQP4-M23 onto
astrocytic process regulate their motility and tune the basal
transmission at glutamatergic synapses. Furthermore, the dy-
namic organization of AQP4-M23 is bi-directionally regulated
by neuronal activity, supporting the presence of functional inter-
play between astrocytic motility and neuronal network activity.
Autoantibodies directed against AQP4 from NMO patients alter
the AQP4 surface dynamics, leaving intact their function. As a
consequence, these autoantibodies impair the AQP4-depen-
dent astrocytic process motility and basal transmission of gluta-
matergic synapses, consistent with the major defect of neuronal
network in this disorder (Marignier et al., 2010, 2016). Although
the molecular mechanisms underlying the regulation AQP4-
M23 in these conditions remain enigmatic, these data fuel a
model in which the membrane redistribution of AQP4-M23 in
nanoscale clusters favors the rapid adaptation of astrocytic pro-
cess volume andmotility, affecting the basal transmission of glu-
tamatergic synapses.
Astrocytic processes are thin and highly motile structures that
respond to synaptic activity and long-term synaptic plasticity
(Bernardinelli et al., 2014; Oliet et al., 2001; Perez-Alvarez
et al., 2014). For instance, high synaptic activity is associated
with a transient decrease in the extracellular space surrounding
synapses (Dietzel et al., 1980), often related to the swelling of
astrocyte processes. Indeed, an increase in synaptic activity in-
creases the extracellular concentration of glutamate and potas-
sium, whose clearance from the synaptic cleft requires astrocyte
water influx through AQP4 (Haj-Yasein et al., 2012; Nagelhus and
Ottersen, 2013). Currently, the structural adaptations of astro-
cyte processes are envisioned to be mediated by swelling-
shrinking through water fluxes (Reichenbach et al., 2010) and
actin-dependent mechanism (Haber et al., 2006). For instance,
actin-depolymerizing molecules alter chloride and ionotropic
fluxes at the plasma membrane, leading to morphological adap-
tations comparable with those observed in hypo-osmotic condi-
tions (Lascola et al., 1998). Furthermore, swelling of perisynaptic
glial processes through water intake causes transient rises in
calcium that trigger actin depolymerization (Newman, 2001).
Thus, water- and actin-dependent mechanisms likely work syn-
ergistically to tune the astrocyte process swelling and motility
(Saadoun et al., 2005). We now report that the local regulation
(F) Representative time-lapse images (!14 s duration) of spontaneous synaptic NMDAR-mediated Ca2+ transients in basal condition and after AQP4-M23 or
AQP4-M1 x-link. Surface AQP4-M1 or AQP4-M23 clusters are highlighted in red. Note that the NMDAR antagonist APV (50 mM) fully blocks spontaneous synaptic
NMDAR-mediated Ca2+ transients. Scale bars, 20 mm and 2 mm (enlarged transients). Lower panel: fluorescence versus time trace of spontaneous synaptic
NMDAR-mediated Ca2+ transients in control (Ctrl), AQP4-M1, or AQP4-M23 immobilization by x-link and in the presence of APV (50 mM). Right: comparison
of NMDAR-mediated Ca2+ transient frequency (M23ctrl, n = 21; M23x-link, n = 21; M1ctrl, n = 21; M1x-link, n = 17 protrusions). The calcium fluorescent change is
calculated from the ratio DF/F.
Data are presented in (A) as SD (*p = 0.02, Mann-Whitney test) and in (B) as mean ± SEM (***p < 0.0001, Mann-Whitney test). In (C) and (D), ***p < 0.0001 (Mann-
Whitney test). Data are presented in (E) as mean ± SEM (*p = 0.04, Mann-Whitney test) and in (F) as mean ± SEM (**p = 0.0026, Student’s t test).
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Figure 7. NMO-IgG Alters AQP4 Surface Diffusion, Astrocytic Motility, and Synaptic Activity
(A) IgG from NMO patients was purified and used to label surface AQP4.
(B) Survival rates of oocytes expressing no AQP4, AQP4-M1myc (M1), or AQP4-M23myc (M23) and exposed to control (Ctrl IgG) or NMO IgGs (n = 60 oocytes
injected for each condition; no statistical difference between IgG conditions, one-way ANOVA).
(C) Representative trajectories of AQP4-M23myc onto astrocytes exposed to control or NMO IgGs. Right: comparison of the instantaneous diffusion coefficients
between conditions (AQP4-M23: nctrl = 1,300, nNMO = 2,000 trajectories; ***p < 0.0001, Mann-Whitney test). Scale bars, 0.5 mm.
(D) Representative trajectories of AQP4-M1myc onto astrocytes exposed to control or NMO IgGs. Right: comparison of the instantaneous diffusion coefficients
between conditions (AQP4-M1: nctrl = 1,547, nNMO = 2,882 trajectories; ***p < 0.0001, Mann-Whitney test). Scale bars, 0.5 mm.
(E) Effect of NMO IgG on AQP4-M23myc (orange) and AQP4-M1myc (blue) cluster area (nAQP4-M23 = 10, nAQP4-M1 = 9 astrocytes; **p = 0.003 and ***p < 0.0001,
Mann-Whitney test).
(F) Time-lapse imaging of GFP-expressing astrocyte processes before and after NMO IgG incubation. Arrowheads highlight extension, and circles highlight
retraction. Quantification of process motility (P.M.) from individual process (nNMO = 170, nCtrl = 130 regions from 12 astrocytes). Scale bar, 2 mm.
(G) Time-lapse imaging of spontaneous synaptic NMDAR-mediated Ca2+ transients in the presence of control or NMO IgGs. Right: comparison of NMDAR-
mediated Ca2+ transient frequency between conditions (mean ± SEM; Ctrl IgG, n = 20; NMO IgG, n = 20 spines; ***p < 0.0001, Student’s t test). The calcium
fluorescent change is calculated from the ratio DF/F. Scale bar, 2 mm.
Data are presented in (C) and (D) as median ± IQR, in (E) as mean 3 105 ± SEM, and in (F) as SD.
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of the water transporter AQP4-M23 in astrocytic processes is
instrumental in tuning process motility. Although both AQP4-
M1 and AQP4-M23 diffuse at the surface of astrocytic pro-
cesses, like other membrane proteins in astrocytes (Arizono
et al., 2012; Murphy-Royal et al., 2015; Al Awabdh et al., 2016),
important differences between isoforms were unveiled. For
instance, AQP4-M1 was highly dynamic and homogeneously
distributed into small nanoscale clusters, whereas AQP4-M23
slowly diffuses and aggregates into large clusters on motile pro-
cesses. Interestingly, the presence of neurons and the neuronal
activity tune the surface dynamics of AQP4-M23, consistent with
former reports in pure astrocyte preparations (Crane et al., 2008,
2010). Thus, in both in vitro and ex vivo hippocampal networks,
AQP4-M23 dynamics and nanoscale cluster organization reflect
the status of the neuronal network activity and likely serve in the
homeostatic regulation of the tripartite synapse. We acknowl-
edge that the present data were collected solely in astrocytes
from hippocampal cultures and organotypic slices, which may
not fully capture the in vivo polarization of AQP4 distribution on
astrocyte endfeet. Yet AQP4 subtypes were differentially orga-
nized, in agreement with the well-described larger AQP4-M23
assemblies (Crane et al., 2010). Furthermore, AQP4-M23 clus-
ters with similar organization were previously described in the
brain parenchyma; clusters that were significantly smaller
compared with AQP4-M23 endfeet in perivascular areas (Smith
and Verkman, 2015). Thus, the described surface dynamics
and spatial distribution of AQP4-M23 are consistent with previ-
ous work and surely shed light on AQP4 regulation in brain
networks.
Although the molecular mechanism underlying this regulation
remains unknown, one may speculate that the activation of
astrocytic metabotropic glutamate receptor and subsequent
calcium-calmodulin-dependent protein kinase II (CaMKII) phos-
phorylate AQP4 (Gunnarson et al., 2005, 2008), a process known
to strongly influence receptor and transporter surface dynamics
(Battaglia et al., 2018; Carta et al., 2013; Folci et al., 2018; Gian-
none et al., 2013; Opazo et al., 2010; Schweitzer et al., 2017).
Additionally, protein-protein interactions with scaffolding pro-
teins (Choquet and Triller, 2013) or other transmembrane pro-
teins, such as the Na+/K+ ATPase (Illarionova et al., 2010), can
also play an important role in this process. As it has been recently
shown that the astrocytic glutamate transporter GLT-1 is dynam-
ically anchored near synapses (Murphy-Royal et al., 2015), the
presence of macromolecular complexes containing glutamate
and water transporters, as well as glutamate receptors, in this
strategic location may serve as ‘‘sensing’’ and ‘‘plastic’’ entities,
enabling the local adaptations of astrocytic processes with the
synaptic activity.
The role of AQP4 in synaptic long-term plasticity, learning, and
memory has been supported by several lines of evidence
(Scharfman and Binder, 2013; Szu and Binder, 2016; Wu et al.,
2017; Yang et al., 2013). For instance, mice in which the AQP4
gene has been knocked out display impaired NMDAR-depen-
dent long-term potentiation and depression at hippocampal glu-
tamatergic synapses (Li et al., 2012). Moreover, changes in
AQP4 expression have been associated with altered neuronal
network acidity and neuronal excitability (Binder et al., 2012).
How would a change in astrocytic AQP4 relate to NMDAR-
dependent alteration of the glutamate synapse? Together with
our observations that AQP4-M23 nanoscale dynamics regulate
astrocyte process motility and NMDAR-mediated synaptic
events, we propose that AQP4 aggregation favors the astrocytic
coverage of glutamate synapse, altering the concentration of
glutamate in the synaptic cleft and its vicinity (Oliet et al., 2001;
Theodosis and Poulain, 1993; Theodosis et al., 2008), as well
as the release of gliotransmitters, such as D-serine, which are
essential for NMDAR activation in hippocampal synapse (Henne-
berger et al., 2010; Panatier et al., 2006). Thus, activity-depen-
dent changes in AQP4-M23 distribution on motile astrocytic
processes can tune the recruitment of NMDAR signaling and,
as a consequence, NMDAR-dependent plasticity processes.
Our capability to alter the surface trafficking of AQP4 in a time-
dependent manner is likely more sensitive than a total knockout
approach (AQP4"/"), for which compensations might explain
that synaptic transmission has been found altered only after
potentiation but not under basal conditions (Scharfman and
Binder, 2013; Szu and Binder, 2016; Wu et al., 2017; Yang
et al., 2013).
Finally, understanding how AQP4 is functionally organized
and participates in the dialog between astrocytes and neurons
is also a major challenge for clinics, as most patients with
NMO spectrum disorder show autoantibodies targeting
AQP4. Our data indicate that these autoantibodies are acutely
deleterious by themselves (i.e., without cell or complement
cytotoxicity), not because they block the water transport flux
but because they displace membrane AQP4 isoforms and
set a functional nanoscale organization that strongly restrains
astrocyte process motility. Indeed, the binding of NMO-IgG to
AQP4 bi-directionally modifies AQP4-M1 and AQP4-M23
surface diffusion. The consequences on astrocyte process
motility and glutamate synapse transmission, which are signif-
icantly decreased, are well in line with what could be predicted
on the basis of x-link manipulations. These alterations could
also be combined with additional effects of NMO-IgG on the
glutamate uptake from astrocytes and consequent glutamate
excitotoxicity that have been involved in the pathogenesis of
long-term exposure to NMO (Hinson et al., 2008; Marignier
et al., 2010, 2016). This work thus provides direction for a
molecular and cellular framework to better characterize the
molecular dysregulation underpinning NMO spectrum disor-
ders. Noteworthy, this ‘‘single-molecule’’ study of this autoim-
mune disease echoes, to some extent, recent investigations in
which the impact of autoantibodies directed against the
glutamatergic NMDAR and purified from patients with neuro-
psychiatric conditions has been identified (Je´ze´quel et al.,
2017; Krugers et al., 2010; Mikasova et al., 2012). These
studies unveiled that autoantibodies that target extracellular
epitopes of the NMDAR do not alter its ionotropic function
but displace the receptor from the postsynaptic density to
the extrasynaptic membrane compartment in which the recep-
tor is later endocytosed. Beyond a better understanding of the
cellular and molecular mechanisms involved in autoimmune
diseases of the CNS, such study has also opened avenues
of research for innovative therapeutically strategies in which
a balance of the dynamics and distribution of the autoantibody
target is explored.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
Mixed hippocampal culture of glia and neurons were prepared from E18 Sprague-Dawley rats, as previously described (Bard et al.,
2010; Groc et al., 2004). Dissociated cells were plated at a density of 30 3 104 cells per dish on poly-L-lysine (Sigma-Aldrich) pre-
coated diameter glass coverslips. Cultures were maintened in neurobasal medium (GIBCO) with 3% horse serum (vol/vol, Invitrogen)
for several days before changing to serum-free neurobasal medium supplemented with B-27 and L-glutamine. Cultures were kept in
a humidified incubator at 37#C in 5% CO2.
Human sera and IgG purification
Sera were obtained from three patients with NMO spectrum disorder, as previously described (Marignier et al., 2016). In addition, we
used sera from three healthy blood donors from Etablissement Franc¸ais du Sang (Marignier et al., 2016). According to the French law
on bioethics (July 29, 1994; August 6, 2004; and July 7, 2011, Public Health Code), the patients’ written informed consent was
collected. Moreover, data confidentiality was ensured in accordance with the recommendations of the French commission for
data protection (Commission Nationale Informatique et Liberte´, CNIL decision DR-2014-558). Sex and age of patients were un-
known, as experimentations were performed from blinded sera provided by the Lyon biobank, only characterized by their AQP4-
Ab positive serostatus. Briefly, IgG were purified and concentrated to obtain an IgG concentration of 2 mg.ml-1. For cell experiments,
IgG were incubated for 30 min.
Organotypic slices
Hippocampal organotypic slices were prepared as previously described (Varela et al., 2016b). Briefly, 350 mm-thick hippocampal
slices were obtained from postnatal day 5-7 Sprague-Dawley rats using a McIlwain tissue chopper and were placed in dissection
medium containing (in mM): 175 sucrose, 358 D-glucose, 50 NaCl, 0.5 CaCl2, 2.5 KCl, 0.66 KH2PO4, 2 MgCl2, 0.28 MgSO4-
7H2O, 0.85 Na2HPO4-12H2O, 2.7 NaHCO3, 0.5 HEPES pH 7.3 (Sigma). After 25 min incubation, slices were transferred on white
FHLC membranes (0.45 mm) set on Millicell cell culture inserts (Millipore, 0.4 mm; Ø 30 mm) and cultured for up to 10-14 days on
multiwell plates at 35#C/5%CO2 in a culture medium containing: 200ml basal medium eagle (#41010-026), 100ml Hank’s balanced
salt solution 1M (#15630056), complemented with 0.45% glucose, 1 mM L-Glutamine, 25% heat inactivated horse serum
(# 10368902) (GIBCO). The medium was changed every 2 to 3 days.
METHOD DETAILS
Cell culture transfection
Cells were transfected at 10-12 days in vitro (d.i.v.) using Effectene transfection kit (QIAGEN) with plasmids coding for Enhanced
Green Fluorescent Protein (EGFP) and AQP4-M1myc or AQP4-M23myc corresponding to AQP4 (Origene-SC108945) with a ten-resi-
dye Myc epitope (EQKLISEEDL) in their second extracellualr loop (Crane et al., 2008) and maintend between 24-48 hours before ex-
periments. Astrocytes constitute the vast majority of transfected cells and only GFP and AQP4myc co-expressing astrocytes were
taken into consideration for analyses. To label synapses, neurons were transfected at d.i.v. 5 with either Homer-dsRed or GCaMP3
plasmids using calcium-phosphate coprecipitation method (Jiang and Chen, 2006). For primary glia cultures (neuron free), cells were
diluted to a density of 2 3 105 cells/ml in Dulbecco’s modified Eagle Medium (DMEM, Invitrogen) supplemented with 1% glutamax
(vol/vol, GIBCO), 1% sodium pyruvate (vol/vol, Sigma-Aldrich) and kept for 20 d.i.v.; neurons were then removed by a mechanical
shake of plate.
Immunohistochemistry
In order to immunostain mixed cultures, cells were first fixed with 4% paraformaldehyde/4% sucrose in PBS for 15 min, permeabi-
lized using 0.1% Triton X-100 (vol/vol) and incubated with different primary antibodies overnight: astrocytes were stained with GFAP
antibody (1:1000, Dako), neurons withMAP2 antibody (1:500, EnCor Biotechnology Inc), microglia with Iba1 (1:500, Abcam). The day
after, cells were incubated with specific secondary antibodies. For endogenous AQP4 staining (Figure S1A), cells were first trans-
fected respectively with no plasmid, eGFP, AQP4-M1myc or AQP4-M23myc and in the latest two samples, incubated for 30 min
with antibody to myc (to tag transfected cells). Cells were then fixed, permeabilized and labeled with AQP4 antibody that recognized
the intracellular epitope (10 mg/ml, 1 h; Merck-AB3594) and thus mark all AQP4 (both endogenous and exogenous).
For live immunolabeling of AQP4myc, surface AQP4-M1myc or AQP4-M23myc were stained using a monoclonal antibody to Myc
(10 mg/ml; clone 9E10, Origene Technologies) for 30 min on lived mixed cultures at 37#C and 5% of CO2. For live surface labeling
of endogenous AQP4, cells were incubated with NMO immunoglobulins (0.4 mg.ml-1, 30 min). Cells were then fixed with 4% para-
formaldehyde/4% sucrose in PBS for 15 min, washed and then incubated with appropriate secondary antibodies. Surface AQP4myc
staining was compared before and after fixation with 4% paraformaldehyde/4% sucrose in PBS, 15min. To quantify the cluster area,
an Alexa 488 conjugated goat anti mouse (1 h; Jackson ImmunoResearch) was used as secondary antibody. To label Homer, neurons
were permeabilized using 0.1% Triton X-100 (vol/vol) and incubated with a primary rabbit polyclonal antibody to Homer 1/2/3
(1:500, 1 h; Synaptic System) and then incubated with a secondary goat antibody to rabbit conjugated with Cyanine 3 (1 h; Jackson
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ImmunoResearch). Coverslips were mounted on slides with Vectashield (Vector Laboratories). Immunofluorescence signals were
observed with a confocal microscope (Leica DM5500 TCS SPE) equipped with 63X oil objective and 4 diodes laser (405, 488,
561, 635 nm). Images were acquired along the z-axis at 0.5 mm intervals and maximum projection of z stacks was generated. Quan-
titative analysis was performed with ImageJ (1.50b, NIH). For co-localization study, only AQP4 signals within a pre-defined synaptic
area were included. For cluster area, images were analyzed using the Image-based cluster analysis.
Organotypic slices electroporation
Electroporation of cDNA encoding for AQP4-M1myc or AQP4-M23myc and EGFPwas performed at d.i.v. 4 using the Primary Cell Opti-
mization 4D-NucleofectorTM Y Kit (from Lonza, #V4YP-1A24). Briefly, organotypic slices are cultured within 6-well culture plates on
cell culture inserts. For the electroporation step, a 24-well dipping electrode array is inserted into a 24-well plates provided with the
kit, after transferring the slices to the wells and adding the specific NucleofectorTMSolutionmixedwith the cDNA substrate (from 1 to
10 mg/ml). For immunohistochemistry, hippocampal slices were first fixed with 4%paraformaldehyde/4% sucrose in PBS for 2 hours,
permeabilized using 0.3% Triton X-100 (vol/vol) + 1%BSA for 2 hours and then incubated with NMO immunoglobulines (0.4 mg.ml-1,
overnight). Goat anti-humain Alexa 568 antibody (1:1000, 2 hours, Thermo Scientific) was used as secondary antibody. Slices were
mounted on slides with Vectashield (Vector Laboratories) and imaged at the same way as described for cultures.
Quantum dots labeling and imaging
In order to track surface AQP4 using single nanoparticle imaging, samples were incubated for 10 min (for primary culture) or 20 min
(for organotypic slices) with myc antibody (10 mg.ml-1, 10 min; clone 9E10, Origene Technologies) at 37#C, as previously described
(Groc et al., 2007; Varela et al., 2016b). Cells were then washed and incubated respectively for 10-20 min (37#C) with quantum dot
(QD) 655 goat F(ab’) antibody (1 mg.ml-1; Invitrogen). Non-specific binding was blocked by addition of 1% BSA (vol/vol, Vector Lab-
oratories) to the quantum dot (QD) containing solution. Cells were washed and mounted in a Ludin chamber containing artificial ce-
rebrospinal fluid (aCSF) solution (115 mM NaCl, 1.5 mM KCl, 1.6 mM CaCl2, 1.6 MmMgCl2, 8.5 mM HEPES and 8.5 mM D-glucose;
osmolarity was 250-260 mosml kg-1; ph 7.4). The lateral diffusion of AQP4-M1myc and AQP4-M23myc was recorded with a Nikon mi-
croscope (NIKON Eclipse TE2000-U) with a stage heated to 37#C using an air blower (World Precision Instruments) and an objective
heater (Bioptechs). QD were detected using a mercury lamp and appropriate excitation/emission filters. Images were recorded with
an integration time of 50 ms for 500 consecutive frames (25 s) and signals were detected using an EM-CCD camera, and image anal-
ysis performed using MetaMorph software (Molecular Devices). QD were followed on randomly selected GFP-expressing astrocytes
and tagged with AQP4-M1myc or AQP4-M23myc. The instantaneous diffusion coefficient ‘‘D’’was calculated for each trajectory, from
linear fits of the first four points of the mean square displacement versus time function usingMSD(t) = < r2 > (t) = 4Dt. The two-dimen-
sional trajectories of single molecules in the plane of focus were reconstructed by correlation analysis between consecutive images
using a Vogel algorithm. Synaptic dwell-time was calculated and defined as the mean time spent in the synaptic area (defined as the
Homer cluster + 500 nm annulus around it). For different experimental conditions, antibody or drugs were added to the bath: x-link
(same antibody against themyc tag as the one used for surface tracking but at higher concentration: 200 mg.ml-1, 30min, clone 9E10,
Origene Technologies), NMO-IgG or healthy-IgG (0.4 mg.ml-1, 30 min), TTX (1 mM, 20 min; Tocris), L-glutamate (100 mM, 20 min,
Sigma-Aldrich). For the acid wash experiment (Tardin et al., 2003) (Figure S1C), a low pH (pH 2) of aCSF at 4#C was used. Cells
were imaged and left for 10, 15, 20 and 30 min intervals before 1 min of incubation with cold aCSF (pH 2) to break antibody-proteins
bonds and so the only transporters with QDs still attached are the ones that have been internalised. Another QD imaging series was
acquired after removing and replacing with aCSF pH 7.4 at 37#C.
dSTORM and Image-based cluster analysis
For dSTORM experiments, at div 12-14 live transfected cells were first incubated with 1% BSA (Sigma-A3059) added directly in the
culture dish for 5min at 37#Cand specifically stained for surfacemyc labeling (10 mg/ml; anti-myc, clone 9E10, Origene Technologies)
for 30 min at 37#C. Fixation using 4% paraformaldehyde/4% sucrose in PBS (15 min, room temperature) was followed by a 40 min
blocking step with a solution containing 1.5% bovine serum albumin/0.1% fish skin gelatine (Sigma-G7765) 0.1% Triton X-100 for
40 min. Cells were then incubated with anti-mouse AlexaFluor647 (Thermo Scientific-A31571, 1mg/ml) during 30 min and fixed for
a second time in order to avoid dissociation of the labeling before image acquisition. The labeled astrocytes were imaged within
24 hours using a commercial Leica GSDIM super-resolution microscope (Leica Microsystems, Wetzlar, Germany). The microscope
was fitted with an HC PL APO 160x 1.43 NA oil immersion TIRF objective (Leica) enabling detection of single fluorophores. For
dSTORM imaging, the samples were mounted in a closed Ludin chamber containing an extracellular switching buffer supplemented
with oxygen scavengers and reducing agents. Photoswitchable AlexaFluor647 was excited in TIRF mode using first a high 642 nm
laser power (50% of full power) to achieve single molecule blinking, followed by a lower power (15% of full power) during the
acquisition. The intensity of the 405 nm laser (30mW) was continuously adjusted in order to keep an optimal number of stochastically
activated molecules. Fluorescence emission of the AlexaFluor647 was detected by an EMCCD iXon camera (ANDOR, Belfast, UK)
with an exposure time of 10.85 ms in a total of 100.000 consecutive frames. Particle detection threshold was set to 20 in the Leica
LAS software and multicolor fluorescent microbeads (T7279 TetraSpeck, Life Technologies) were used for lateral drift correction.
dSTORM images were reconstructed using a fitting algorithm by the Leica LAS software using a 2-dimensional Gaussian fitting
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algorithm. These images were then analyzed using ImageJ software (ImageJ 1.50b, NIH). Briefly, images were thresholded and the
analyze particles function was used to determine the number and area of AQP4-M1 and AQP4-M23 clusters, respectively.
Time-lapse imaging and analysis
For time-lapse experiments, cells were transfected with GFP and AQP4-M1myc or AQP4-M23myc before live immunostaining for
AQP4myc using a monoclonal antibody to myc (10 mg/ml, 15 min; clone 9E10, Origene Technologies) followed by a secondary
goat antibody to mouse conjugated with Cy3 (15 min; Jackson ImmunoResearch). For time-lapse experiments with labeled synap-
ses, presynaptic terminals were labeled with 10 mM of FM4-64 dye (Molecular Probes-T13320) in a solution containing 60 mM of KCl
at the end of each acquisition. Time-lapse imaging was performed on a Spinning-disk LIFA microscope (Leica DMI6000B) with a 40X
dry objective, with four diodes laser (408, 491, 561, 638 nm) and a stage heated to 37#C. Z-stacks of GFP labeling were acquired
every minute during 30 min using MetaMorph software (Molecular Devices). Quantitative analysis was performed with ImageJ soft-
ware. Briefly, maximum projection of z stacks was generated followed by x,y-axis movement correction using stackreg plugin. Im-
ages were then thresholded, filtered with 3x3mean filter and binarized (Bernardinelli et al., 2014). The area of processes for each time
point was finally calculated. Changes in area (astrocytic movement) over time were measured from the standard deviation of 30 im-
ages over time (Figures S2A and S2B). For experiments with labeled synapses, only GFP-expressing astrocytes within a pre-defined
synaptic area were included. For different experimental conditions, antibody or drugs were added to the bath: x-link (200 mg.ml-1,
clone 9E10, Origene Technologies, 30 min), NMO-IgG or healthy-IgG (0.4 mg.ml-1, 30 min), TTX (1 mM, 20 min; Tocris), L-glutamate
(100 mM, 20 min, Sigma-Aldrich).
Osmotic swelling assay
Oocytes were removed from Xenopus laevis as previously described (Jo et al., 2011; Toulme´ et al., 2006). After nuclear injection of
cDNAs coding for AQP4-M1myc or AQP4-M23myc (300 pg each), oocyteswere incubated in Barth’s solution containing 1.8mMCaCl2,
pyruvic acid (0.5 mg/ml) and gentamycin (50 mg/ml, Sigma-Aldrich) at 19#C for 2-3 days before experiments. Oocytes were then
exposed to myc antibody (10 mg.ml-1 or 200 mg.ml-1 for x-link experiments, 30 min, clone 9E10, Origene Technologies) or NMO-
IgG or healthy-IgG (0.4 mg.ml-1, 30 min) and then immersed to distillate water (Madeira et al., 2016). Lysis time was observed
with a Macroscope Leica Z 16 APO. To confirm that the cell swelling was due to the presence of AQP4, we exposed the oocytes
with two AQP4 inhibitors: bumetanide (75 mM; Sigma-Aldrich-B3023) intracellularly injected and TGN-020 (500 mM; Sigma-Al-
drich-SML0136) in the extracellular solution for 30 min before immersion into water. Death rate and fold in lysis time were calculated
by comparing the average of live oocytes from three independent experiments.
Calcium imaging and analysis
For calcium imaging experiments, neurons were transfected with GCaMP3 and astrocytes with GFP/AQP4-M1myc or GFP/AQP4-
M23myc plasmids before live immunostaining for AQP4myc using a monoclonal antibody to myc (10 mg/ml, 15 min; clone 9E10,
Origene Technologies) followed by a secondary goat antibody to mouse conjugated with Cy3 (15 min; Jackson ImmunoResearch).
Calcium imaging was performed after 15min of incubation in aCSFMg2+ free solution (110mMNaCl, 5mMKCl, 2mMCaCl2, 8.5mM
HEPES and 8.5 mM D-glucose; osmolarity was 250-260 mosml kg-1; ph 7.4) with Ca2+ current blockers bicuculline (5 mM; Alomone
labs-B135) and nifedipine (5 mM; Tocris). Changes in GCaMP3 signal were acquired with Spinning-disk LIFA microscope (Leica
DMI6000B) with a 63X oil objective, an EMCCD camera and a stage heated to 37#C. Images were acquired at 20 Hz with 50 ms
of exposure time. DL-APV (50 mM; Tocris-0105) was added at the end of experiments for 5 min before images recorded. Calcium
signal was detected from randomly selected GCaMP3 neurons facing astrocytes tagged with AQP4-M1myc or AQP4-M23myc and
recorded with MetaMorph software. Data analysis were carried out as described in Patel et al. Briefly, ROIs of spines were first delin-
eated and the fluorescence versus time trace was calculated with MATLAB script (Patel et al., 2015). The fluorescence ratio (DF/F)
was quantified and a threshold at 0.2 was used to determine peak calcium fluorescence.
QUANTIFICATION AND STATISTICAL ANALYSIS
All quantitated analysis were performed with the researcher blind to the condition.
All data were acquired from at least three independent batches of cells. Detailed for experiment parameters are provided in the
Supplemental Data Analysis Table S1. Data are presented as mean ± s.e.m., median ± IQR or standard deviation. All statistical tests
were carried out using GraphPad Prism 6.0. Significance was assessed by performing the Mann-Whitney U, the Pearson correlation
test, One-way ANOVA and Student’s t test.
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